Inventor
GALLAGHER GRANT
US24 patents
⚠️ This page may combine multiple inventors who share the name “GALLAGHER GRANT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GALLAGHER GRANT
14 patentsUS9169292B2Oct 27, 2015
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
GALLAGHER GRANT34 citations93
US8946150B2Feb 3, 2015
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
GALLAGHER GRANT34 citations93
US9605027B2Mar 28, 2017
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
GALLAGHER GRANT6 citations82
US9868776B2Jan 16, 2018
Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases
GALLAGHER GRANT1 citations61
US8282964B2Oct 9, 2012
Ex-vivo treatment of peripheral plasmacytoid dendritic cells with IFN-lambda
GALLAGHER GRANT3 citations57
US10416172B2Sep 17, 2019
Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling
GALLAGHER GRANT0 citations51
US9187750B2Nov 17, 2015
Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases
GALLAGHER GRANT0 citations51
US8618070B2Dec 31, 2013
Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases
GALLAGHER GRANT0 citations51
US9523073B2Dec 20, 2016
Elisa for a naturally-occurring soluble truncated form of IL-23 receptor
GALLAGHER GRANT0 citations50
US10144974B2Dec 4, 2018
Methods and reagents that specifically detect, distinguish and quantify IFN-LAMBDA2 mRNA from IFN-LAMBDA3 mRNA in humans
GALLAGHER GRANT0 citations47
US9464321B2Oct 11, 2016
Methods and reagents that specifically detect, distinguish and quantify IFN-λ2 mRNA from IFN-λ3 mRNA in humans
GALLAGHER GRANT0 citations47
US8206925B2Jun 26, 2012
Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a delta 9 isoform in predicting inflammatory bowel diseases
GALLAGHER GRANT0 citations46
US8354125B2Jan 15, 2013
Ex-vivo treatment of peripheral blood leukocytes with IFN-λ
GALLAGHER GRANT0 citations42
US8771666B2Jul 8, 2014
Ex-vivo treatment of T-cells with IFN-λ
GALLAGHER GRANT0 citations40
MEDICAL DIAGNOSTIC LAB LLC
4 patentsUS9163238B2Oct 20, 2015
Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity
MEDICAL DIAGNOSTIC LAB LLC0 citations48
US8349808B2Jan 8, 2013
Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity
MEDICAL DIAGNOSTIC LAB LLC0 citations48
US8802648B2Aug 12, 2014
Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity
MEDICAL DIAGNOSTIC LAB LLC0 citations45
US8933049B2Jan 13, 2015
Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity
MEDICAL DIAGNOSTIC LAB LLC0 citations42
MEDICAL DIAGNOSTIC LABORATORIES LLC
2 patentsUSRE49026EApr 12, 2022
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
MEDICAL DIAGNOSTIC LABORATORIES LLC0 citations60
US9506066B2Nov 29, 2016
Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-λ gene activity
MEDICAL DIAGNOSTIC LABORATORIES LLC0 citations48